| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LOPINAVIR; RITONAVIR | 090471 | 001 | ANDA | LOPINAVIR; RITONAVIR | TABLET; ORAL | 100MG; 25MG | No | No | 2009/03/10 (TA) | -- | AUROBINDO PHARMA LTD | None (Tentative Approval) |
| LOPINAVIR; RITONAVIR | 090471 | 002 | ANDA | LOPINAVIR; RITONAVIR | TABLET; ORAL | 200MG; 50MG | No | No | 2009/03/10 (TA) | -- | AUROBINDO PHARMA LTD | None (Tentative Approval) |
| LOPINAVIR; RITONAVIR | 090371 | 001 | ANDA | LOPINAVIR; RITONAVIR | TABLET; ORAL | 200MG; 50MG | No | No | 2009/11/20 (TA) | -- | CIPLA LIMITED | None (Tentative Approval) |
| LOPINAVIR; RITONAVIR | 091202 | 001 | ANDA | LOPINAVIR; RITONAVIR | TABLET; ORAL | 100MG; 25MG | No | No | 2011/06/08 (TA) | -- | MYLAN PHARMA | None (Tentative Approval) |
| LOPINAVIR; RITONAVIR | 091202 | 002 | ANDA | LOPINAVIR; RITONAVIR | TABLET; ORAL | 200MG; 50MG | No | No | 2011/06/08 (TA) | -- | MYLAN PHARMA | None (Tentative Approval) |
| LOPINAVIR; RITONAVIR | 091203 | 001 | ANDA | LOPINAVIR; RITONAVIR | SOLUTION; ORAL | 80MG; 20MG | No | No | 2012/06/29 (TA) | -- | CIPLA LIMITED | None (Tentative Approval) |